Published

Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Experientia
Date: 1974-12-15
Source: PubMed
DOI: 10.1007/bf01919685
PubMed: 4442544

Authors

Fanciullacci M Franchi G Sicuteri F

Watch author

Derived topics and classifications

psilocybin Headache / Migraine Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01 Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.1974-12-15

Related papers

Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Headache · 2011-03-01 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09 Repeat Dosing of Psilocybin in Headache DisordersClinicalTrials.gov · 2024-02-09 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01